INTENDED USE
All of Rapid DOA Panel Test is an immunochromatography based one step in vitro test. It is designed for qualitative determination of drug substances in human urine specimens. This assay may be used in the point of care setting. Below is a list of cut-off concentrations for each drug using our test.
|
Drugs of Abuse
|
Cut-off Level
|
|
Amphetamine
|
1000 ng/ml of d-amphetamine
|
|
Barbiturate
|
300 ng/ml of secobarbital
|
|
Benzodiazepine
|
300 ng/ml of oxazepam
|
|
Buprenorphine
|
10 ng/ml of Buprenorphine-3-β-d-glucoronide
|
|
Cocaine
|
300 ng/ml of benzoylecgonine
|
|
EDDP
|
100 ng/ml of EDDP
|
|
Methadone
|
300 ng/ml of methadone
|
|
Methamphetamine (Ecstasy)
|
1000 ng/ml of (+)methamphetamine
|
|
Opiate*
|
300 ng/ml of morphine
|
|
Opiate II*
|
2000 ng/ml of morphine
|
|
Oxycodone
|
100 ng/ml of oxycodone
|
|
Phencyclidine
|
25 ng/ml of phencyclidine
|
|
Cannabinoid (THC)
|
50ng/ml of 11-nor-D9-THC-9-COOH
|
This assay provides only a preliminary analytical test result. A more specific alternative chemical method must be used in order to obtain a confirmed analytical result. Gas chromatography/ mass spectrometry (GC/MS) has been established as the preferred confirmatory method by the Substance Abuse Mental Health Services Administration (SAMHSA). Clinical consideration and professional judgment should be applied to any drug of abuse test result, particularly when preliminary positive results are indicated.
* SAMHSA recommends a cut-off concentration of 2000 ng/ml for Opiates Test
PROCEDURE:
1) Bring all materials and specimens to room temperature.
2) Remove the test card from sealed foil pouch.
3) Place the sample pad end into the urine specimen being careful to hold each pad in the urine without touching the plastic card.
4) Hold the card in the urine for 10 seconds, remove from the urine and replace the cap.
5) Read the results at 5 minutes after adding the sample.
Do not interpret the result after 5 minutes.
|